MedTrace Logo

Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on Weight

NCT00819858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-10-16

No results posted yet for this study

Summary

The primary objective of this study is to determine to what extent provision with RUTF will promote catch up growth in children following an acute uncomplicated episode of P. falciparum malaria.

Conditions

Interventions

DIETARY_SUPPLEMENT

RUTF (Plumpynut®)

Intervention group receives 500 kcal/day of RUTF for 2 weeks Control group receives no food supplement

Sponsors & Collaborators

  • Medecins Sans Frontieres, Netherlands

    lead OTHER

Principal Investigators

  • Saskia van der Kam, Ir · nutrition expert MSF

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Republic of the Congo

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819858 on ClinicalTrials.gov